89bio, Inc. (ETNB) Misses Q2 EPS by 6c

89bio, Inc. (NASDAQ: ETNB) reported Q2 EPS of ($0.52), $0.06 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on 89bio, Inc. (ETNB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79